Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BEBTELOVIMAB Cause Wrong technique in product usage process? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Wrong technique in product usage process have been filed in association with BEBTELOVIMAB. This represents 0.4% of all adverse event reports for BEBTELOVIMAB.

5
Reports of Wrong technique in product usage process with BEBTELOVIMAB
0.4%
of all BEBTELOVIMAB reports
0
Deaths
0
Hospitalizations

How Dangerous Is Wrong technique in product usage process From BEBTELOVIMAB?

Of the 5 reports.

Is Wrong technique in product usage process Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BEBTELOVIMAB. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does BEBTELOVIMAB Cause?

Dyspnoea (242) Infusion related reaction (234) Flushing (196) Nausea (180) Dizziness (167) Chest discomfort (150) Cough (107) Headache (90) Chest pain (88) Back pain (83)

What Other Drugs Cause Wrong technique in product usage process?

EVOLOCUMAB (21,664) ALBUTEROL (17,114) ADALIMUMAB (11,766) PEGFILGRASTIM (10,217) ETANERCEPT (9,835) ERENUMAB-AOOE (9,359) SACUBITRIL\VALSARTAN (8,022) LEUPROLIDE (5,062) FENTANYL (2,812) SEMAGLUTIDE (2,538)

Which BEBTELOVIMAB Alternatives Have Lower Wrong technique in product usage process Risk?

BEBTELOVIMAB vs BECLOMETHASONE BEBTELOVIMAB vs BECLOMETHASONE DIPROPIONATE BEBTELOVIMAB vs BECLOMETHASONE DIPROPIONATE\FORMOTEROL BEBTELOVIMAB vs BECLOMETHASONE\FORMOTEROL BEBTELOVIMAB vs BEDAQUILINE

Related Pages

BEBTELOVIMAB Full Profile All Wrong technique in product usage process Reports All Drugs Causing Wrong technique in product usage process BEBTELOVIMAB Demographics